Dr. Frank Rijsberman leads the Global Green Growth Institute (GGGI) in supporting governments transition towards a model of economic growth that is environmentally sustainable and socially inclusive. With over 30 years’ experience addressing the challenges of environmental sustainability and poverty reduction with leading international organizations and philanthropic foundations, Dr. Rijsberman was appointed as the Director-General of the Institute, on October 1, 2016.

Upon assuming his position, Dr. Rijsberman has engaged with senior international stakeholders to drive the green growth agenda and help mobilize finance for climate action and sustainable development. As an advocate for sustainable development, Dr. Rijsberman is focused on supporting GGGI Member and partner governments to implement their Nationally Determined Contributions (NDCs) under the Paris Agreement and achieve their Sustainable Development Goal (SDG) targets. He holds a PhD degree in water resources management and planning from Colorado State University (US) and a MSc and BS in Civil Engineering from Delft University of Technology (Netherlands).

Jerome Kim, M.D., is the Director General of the International Vaccine Institute (IVI) and an international expert on the evaluation and development of vaccines. His depth and breadth of scientific experience span basic research through advanced clinical development. IVI’s oral cholera vaccine is used around the world to prevent this deadly diarrheal disease. IVI’s typhoid conjugate vaccine, tech-transferred to SK bioscience and PT Bio Farma, is completing Phase III testing. IVI is working on several different vaccines against COVID-19, including the clinical testing of Inovio's DNA vaccine at Seoul National University Hospital and Genexine’s COVID-19 vaccine at Severance Hospital.

Dr. Kim was Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis ,in the U.S. Military HIV Research Program (MHRP) and also served as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity, Fort Detrick, MD. He led the Army's Phase III HIV vaccine trial (RV144) which was the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates and HIV sequence changes associated with vaccination.

Dr. Kim has authored over 250 publications and received the John Maher Award for Research Excellence from the Uniformed Services University of the Health Sciences in 2013 and the Department of the Army R&D Award for Technical Excellence (2013). Dr. Kim is also an Adjunct Professor of Medicine at the Uniformed Services University of the Health Sciences and at Yonsei University Graduate School of Public Health and a Fellow of the American College of Physicians and the Infectious Diseases Society of America. He is a graduate of the University of Hawaii, with high honors in History and highest honors in Biology, and received his M.D. from Yale University School of Medicine.

BARRETT HAZELTINE was Professor of Engineering at Brown University. He is now Professor Emeritus but continues to teach at Brown. From 1972 to 1992 he was also Associate Dean of the College. He is a graduate of Princeton University-BSE - 1953, MSE - 1956 and the University of Michigan-Ph.D. - 1962.

In 1991-92 he held the Robert Foster Cherry Chair for Distinguished Teaching at Baylor University. He was awarded teaching citations from thirteen senior classes at Brown University until the award was named in his honor. In 2015 he received the Susan Colver Rosenberger, the highest award the Brown Faculty can bestow. He has received various other awards.

He has taught at the University of Zambia in 1970 and 1976, at the University of Malawi in 1980-81, 1983-84, and 1988-89, at the University of Botswana in 1993, and Africa University in Zimbabwe-1996-97, 2000, and 2006. Other foreign countries in which he has done teaching or consulting are Bangladesh, Indonesia, Mozambique, Nigeria, and South Africa. He was a Fulbright lecturer in 1988-89 and 1993.

His research deals with appropriate technology, entrepreneurship, and management of technology companies. He teaches courses in these areas, with a particular interest in technological literacy.

Two books he has authored, both with Christopher Bull are: Field Guide to Appropriate Technology and Appropriate Technology:Tools, Choices, and Implications.

He consulted for TechnoServe in Mozambique on a cashew production project and for various other organizations, including Raytheon and the United States Naval Academy. He was a Trustee of Stevens Institute of Technology and was on advisory committees at Baylor University, Roger Williams University, and the State University of New York at Stony Brook. He was also a Trustee of the Paul Cuffee School, a charter school in Providence. He was president of the Providence Engineering Society, the Providence Section of the IEEE, and on the Boards of the Rhode Island Chapter of the Sierra Club, Hamilton House-a senior center, the Capital Good Fund and others.

President Jeyong Yoon of the Korea Environment Institute (KEI) was inaugurated as the twelfth president of KEI in December 2018.

Prior to becoming President of KEI, he was the professor of the Department of Chemical and Biological Engineering at Seoul National University. He has been conducting research for the development of environmental policy for inclusive development with the focus on water environment energy convergence technology, resource recovery and desalination technology. He is also one of the leading figures in appropriate technology and science and technology ODA (Official Development Assistance) serving as the President of the Academic Society for Appropriate Technology and President of the Scientists and Engineers without Borders.

He was appointed as the member of the Presidential Advisory Council on Science and Technology and as the member of the Presidential Committee on Sustainable Development.

He holds a Ph.D. in Civil Engineering from State University of New York at Buffalo.

Jin Yong Kim, MD, MPH of Incheon Center for Infectious Diseases Control and Prevention, was the chief physician of the first confirmed case of Corona 19 in Korea, and he is the creator of the drive-through screening clinic that is being implemented worldwide. He created a drive-through operating plan and schematic in 3 hours. Since 2012, he has been working as a manager at the infection control office, Incheon medical center. He is a graduate of Hanyang University's Graduate School of Public Health, and worked as a doctor at Gachon University Gil Hospital, and was the head of the Incheon Infectious Disease Control Support Group for two years from 2017.